Skip to content
×
Support Us
Sign in or register for your free account
Your Profile
Your Subscriptions
Support Local News
Payment History
Sign Out
Registered Users
Already have an account?
Sign In
New Users
Create a free account.
Register
Support Local News
Sign up for Daily Headlines
Sign up for Notifications
Contact Us
Home
News
Local News
Canada Votes 2025
In the Community
BC News
National News
Indigenous News
World News
Business Wire
Local Sports
National Sports
Cannabis News
Animal Stories
COVID-19
Opioid Crisis
Digital Edition
Opinion
Opinion
Send us a letter
Arts & Life
Local Arts
The Mix
Photos and Videos
Events Calendar
Automotive
Consumer Technology
Food
Health
More Lifestyles
Features
Weatherhood
Driving
Sponsored Content
Spotlight
Homes
Classifieds
View Classified Ads
Place a Classified Ad
Obituaries
View Obituaries
Place an Obituary
Connect
Contact Us
Daily Headlines Email
Support Local News
Print Subscriptions
Search Type
Site
Search
Home
Submissions
Report a Typo or Mistake
Report a Typo or Mistake
Your Name
Optional
Your Email
Optional
Your Phone
Optional
Title
Debate over the abortion pill mifepristone resurfaces after Makary is confirmed to head the FDA
Link
Typo or Mistake
Verify
Submit Report
